Subsequent to year-end, Company named National Seating & Mobility as its exclusive Ekso Indego ® Personal device distributor within the U.S. complex rehabilitation technology (CRT) industry “We are ...

SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and ...

Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology, reported ...

SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...

SAN RAFAEL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...

Ekso Bionics will release its Q4 and full year 2024 financial results on March 3, 2025, with a conference call afterward. Ekso Bionics Holdings, Inc. announced that it will release its financial and ...

Greetings, and welcome to the Ekso Bionics Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow ...

Beta Bionics Inc. reported its Q4 2024 earnings, showcasing significant revenue growth but continuing financial losses. The company’s net sales reached $20.4 million, marking a 145% increase year-over ...

SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and ...